Business Information
The group's principal activities are to design, develop, manufacture and market patented safety needle devices for the healthcare industry. The main patented product is the vanishpoint(R) product that includes 3cc syringes, 1cc tuberculin, insulin, and allergy antigen syringes; 5 abd 10cc syringes; a blood collection tube holder, small tube adapter, a dental syringe, a self retracting iv catheter introducer and a full displacement syringe. The group has an exclusive license granted for the patent rights for a worldwide exclusive license to manufacture, market, sell and distribute products until the expiration of the last of the patents. Acute care hospitals, alternate care facilities, clinics, emergency centers, surgical centers are some of the customers of the group. The products are distributed in the United States and its territories through general line and specialty distributors.
|
|
Name |
Title
|
Email
|
| Thomas Shaw | Chmn., CEO, Pres. | N/A | | Douglas Cowan | CFO, VP, Treasurer | N/A | | Russell Kuhlman | VP - Sales | N/A | | Steven Wisner | Exec. VP | N/A | | James Hoover | Dir. - Quality Assurance | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 25,325 | (3,869) | | 2005 | 24,235 | (1,238) | | 2004 | 21,522 | 54,691
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
